Integrated bioanalytical solutions for drug conjugates
Bioanalytical support for complex drug conjugates
Celerion combines decades of bioanalytical expertise in both small molecules and biologics to support the evolving field of drug conjugates. By combining small and large molecule expertise within one organization, Celerion delivers scientifically integrated solutions for:
- Antibody-Drug Conjugates (ADCs)
- Peptide-Drug Conjugates (PDCs)
- Small Molecule-Drug Conjugates (SMDCs)
- Antibody-Oligonucleotide Conjugates (AOCs)
- Protein-Drug Conjugates
- Aptamer-Drug Conjugates
Simplify outsourcing by partnering with a single CRO that provides comprehensive bioanalytical support across the entire drug conjugate lifecycle.
Comprehensive bioanalytical solutions from a single provider
Drug Conjugates require multiple complementary bioanalytical approaches to support pharmacokinetic and immunogenicity assessment. At Celerion, we maintain top-of-the-line LCMS and immunoassay platforms in our laboratories to provide our clients with customized methods including:
- Total Carrier (antibody, protein, etc.)
- Conjugated Carrier
- Total Payload
- Unconjugated Payload
- Anti-Drug Antibody


